Erratum: hTERT: A novel endogenous inhibitor of the mitochondrial cell death pathway (Oncogene (2006) 25 (4505-4514) DOI: 10.1038/sj.onc.1209487);hTERT: A novel endogenous inhibitor of the mitochondrial cell death pathway

Oncogene

Volumn 25, Issue 33, 2006, Pages 4505-4514

  Massard, C ^a   Zermati, Y ^a   Pauleau, A L ^a   Larochette, N ^a   Metivier D ^a   Sabatier, L ^b   Kroemer, G ^a,c   Soria, J C ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Laboratoire de Radiobiologie et Oncologie   (France)

^c CNRS   (France)

Author keywords

Apoptosis; Bax; Bcl 2; Chemosensitization; p53

Indexed keywords

CISPLATIN; DEATH RECEPTOR; ETOPOSIDE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MITOMYCIN C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN P53; PROTEIN VMIA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HUMAN CELL; KNOCKOUT GENE; MEMBRANE PERMEABILITY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

CYTOMEGALOVIRUS;

EID: 33746851957     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.568     Document Type: Erratum

References (58)

1. Belzacq AS, El Hamel C, Vieira HLA, Cohen I, Haouzi D, Metivier D et al. (2001). Oncogene 20: 7579-7587.
2. Blackburn EH. (2001). Cell 106: 661-673.
3. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L et al. (1999). J Clin Invest 104: 263-269.
4. Cao Y, Li H, Deb S, Liu JP. (2002). Oncogene 21: 3130-3138.
5. Castedo M, Ferri K, Roumier T, Metivier D, Zamzami N, Kroemer G. (2002a). J Immunol Methods 265: 39-47.
6. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A et al. (1996). J Immunol 157: 512-521.
7. Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Andreau K et al. (2002b). EMBO J 21: 4070-4080.
8. Danial NN, Korsmeyer S. (2004). Cell 116: 205-219.
9. Debatin KM, Poncet D, Kroemer G. (2002). Oncogene 21: 8786-8803.
10. Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, Zangemeister-Wittke U et al. (2005). Cell Death Differ 12: 1429-1438.
11. DePinho RA. (2000). Nature 408: 248-254.
12. Folini M, Brambilla C, Villa R, Gandellini P, Vignati S, Paduano F et al. (2005). Eur J Cancer 41: 624-634.
13. Goldmacher VS. (2005). Apoptosis 10: 251-265.
14. Goldmacher VS, Bartle LM, Skletskaya S, Dionne CA, Kedersha NL, Vater CA et al. (1999). Proc Natl Acad Sci USA 96: 12536-12541.
15. Gorbunova V, Seluanov A, Pereira-Smith OM. (2003). J Biol Chem 278: 7692-7698.
16. Green DR, Kroemer G. (2004). Science 305: 626-629.
17. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM et al. (2004). Circ Res 94: 768-775.
18. Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S. (2003). FEBS Lett 536: 180-186.
19. Hanahan D, Weinberg RA. (2000). Cell 100: 57-70.
20. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K. (2001). J Cell Sci 114: 4557-4565.
21. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. (2000). Proc Natl Acad Sci USA 97: 10872-10877.
22. Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A et al. (2005). Hum Gene Ther 16: 685-698.
23. Jacob D, Davis JJ, Zhang L, Zhu H, Teraishi F, Fang B. (2005). Cancer Gene Ther 12: 109-115.
24. Jiang F, Bao J, Li P, Nicosia SV, Bai W. (2004). J Biol Chem 279: 53213-53221.
25. Kang HJ, Choi YS, Hong SB, Kim KW, Woo RS, Won SJ et al. (2004). J Neurosci 24: 1280-1287.
26. Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F et al. (2004). Clin Cancer Res 10: 285-292.
27. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. (1999). Science 285: 1733-1737.
28. Komata T, Kanzawa T, Kondo Y, Kondo S. (2002). Oncogene 21: 656-663.
29. Lantuejoul S, Soria JC, Morat L, Lorimier P, Moro-Sibilot D, Sabatier L et al. (2005). Clin Cancer Res 11: 2074-2082.
30. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. (2002). Nat Genet 32: 107-108.
31. Li S, Crothers J, Haqq CM, Blackburn EH. (2005). J Biol Chem 280: 23709-23717.
32. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, Cunha GR et al. (2004). Cancer Res 64: 4833-4840.
33. Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M et al. (2002). Oncogene 21: 8020-8028.
34. Lu C, Fu W, Mattson MP. (2001). Brain Res Dev Brain Res 131: 167-171.
35. Luiten RM, Pene J, Yssel H, Spits H. (2003). Blood 101: 4512-4519.
36. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB et al. (2005). Proc Natl Acad Sci USA 102: 8222-8227.
37. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB et al. (2003). Cell 114: 241-253.
38. Nicoletti I, Migliorati G, Pagliacci MC, Riccardi C. (1991). J Immunol Methods 139: 271-280.
39. Perfettini JL, Kroemer RT, Kroemer G. (2004). Nat Cell Biol 6: 386-388.
40. Peter ME, Krammer PH. (2003). Cell Death Differ 10: 26-35.
41. Poncet D, Larochette N, Pauleau AL, Boya P, Jalil AA, Cartron PF et al. (2004). J Biol Chem 279: 22605-22614.
42. Rahman R, Latonen L, Wiman KG. (2005). Oncogene 24: 1320-1327.
43. Santos JH, Meyer JN, Skorvaga M, Annab LA, Van Houten B. (2004). Aging Cell 3: 399-411.
44. Saretzki G, Fischer H, Kaufmann IG, Schewe C, Nadjari B, Blohmer J et al. (2001). Anal Cell Pathol 23: 39-43.
45. Schulze-Bergkamen H, Krammer PH. (2004). Semin Oncol 31: 90-119.
46. Smith LL, Coller HA, Roberts JM. (2003). Nat Cell Biol 5: 474-479.
47. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P et al. (2002). Proc Natl Acad Sci USA 99: 12606-12611.
48. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW. (2005). Mol Cell Biol 25: 8037-8043.
49. Uziel O, Fenig E, Nordenberg J, Beery E, Reshef H, Sandbank J et al. (2005). Br J Cancer 92: 1881-1891.
50. Vogelstein B, Lane D, Levine AJ. (2000). Nature 408: 307-310.
51. Vousden KH, Lu X. (2002). Nat Rev Cancer 2: 594-604.
52. Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G, Youle RJ. (1997). J Cell Biol 139: 1281-1292.
53. Wu P, Meng L, Wang H, Zhou J, Xu G, Wang S et al. (2005). Biochem Biophys Res Commun 335: 36-44.
54. Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A et al. (2000). Oncogene 19: 5123-5133.
55. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssière J-L, Petit PX et al. (1995). J Exp Med 181: 1661-1672.
56. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. (2000). Science 290: 989-992.
57. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. (2003). FASEB J 17: 767-769.
58. Zhou C, Gehrig PA, Whang YE, Boggess JF. (2003). Mol Cancer Ther 2: 789-795.